78 related articles for article (PubMed ID: 29539248)
1. Concentration-Dependent Enrichment of Linezolid-Resistant Staphylococcus aureus in an in vitro Dynamic Model.
Alieva KN; Strukova EN; Golikova MV; Portnoy YA; Firsov AA
Antibiot Khimioter; 2016; 61(9-10):28-32. PubMed ID: 29539248
[TBL] [Abstract][Full Text] [Related]
2. Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to linezolid in an in vitro dynamic model.
Firsov AA; Alieva KN; Strukova EN; Golikova MV; Portnoy YA; Dovzhenko SA; Kobrin MB; Romanov AV; Edelstein MV; Zinner SH
J Antimicrob Chemother; 2017 Nov; 72(11):3100-3107. PubMed ID: 28981793
[TBL] [Abstract][Full Text] [Related]
3. In vitro resistance studies with bacteria that exhibit low mutation frequencies: prediction of "antimutant" linezolid concentrations using a mixed inoculum containing both susceptible and resistant Staphylococcus aureus.
Firsov AA; Golikova MV; Strukova EN; Portnoy YA; Romanov AV; Edelstein MV; Zinner SH
Antimicrob Agents Chemother; 2015 Feb; 59(2):1014-9. PubMed ID: 25451050
[TBL] [Abstract][Full Text] [Related]
4. Time inside the mutant selection window as a predictor of staphylococcal resistance to linezolid.
Alieva KN; Strukova EN; Golikova MV; Portnoy YA; Zinner SH; Firsov AA
J Antibiot (Tokyo); 2018 May; 71(5):514-521. PubMed ID: 29348530
[TBL] [Abstract][Full Text] [Related]
5. Enrichment of resistant Staphylococcus aureus at ciprofloxacin concentrations simulated within the mutant selection window: bolus versus continuous infusion.
Firsov AA; Smirnova MV; Strukova EN; Vostrov SN; Portnoy YA; Zinner SH
Int J Antimicrob Agents; 2008 Dec; 32(6):488-93. PubMed ID: 18790614
[TBL] [Abstract][Full Text] [Related]
6. Predicting antibiotic combination effects on the selection of resistant Staphylococcus aureus: In vitro model studies with linezolid and gentamicin.
Zinner SH; Golikova MV; Strukova EN; Portnoy YA; Firsov AA
Int J Antimicrob Agents; 2018 Dec; 52(6):854-860. PubMed ID: 30236953
[TBL] [Abstract][Full Text] [Related]
7. ABT492 and levofloxacin: comparison of their pharmacodynamics and their abilities to prevent the selection of resistant Staphylococcus aureus in an in vitro dynamic model.
Firsov AA; Vostrov SN; Lubenko IY; Arzamastsev AP; Portnoy YA; Zinner SH
J Antimicrob Chemother; 2004 Jul; 54(1):178-86. PubMed ID: 15190041
[TBL] [Abstract][Full Text] [Related]
8. Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to daptomycin and vancomycin in an in vitro dynamic model.
Firsov AA; Smirnova MV; Lubenko IY; Vostrov SN; Portnoy YA; Zinner SH
J Antimicrob Chemother; 2006 Dec; 58(6):1185-92. PubMed ID: 17028094
[TBL] [Abstract][Full Text] [Related]
9. Concentration-dependent enrichment of resistant Enterococcus faecium exposed to linezolid in an in vitro dynamic model.
Alieva KN; Golikova MV; Portnoy YA; Dovzhenko SA; Kobrin MB; Zinner SH; Firsov AA
J Chemother; 2018; 30(6-8):364-370. PubMed ID: 30663551
[TBL] [Abstract][Full Text] [Related]
10. Predictors of bacterial resistance using in vitro dynamic models: area under the concentration-time curve related to either the minimum inhibitory or mutant prevention antibiotic concentration.
Strukova EN; Portnoy YA; Zinner SH; Firsov AA
J Antimicrob Chemother; 2016 Mar; 71(3):678-84. PubMed ID: 26626718
[TBL] [Abstract][Full Text] [Related]
11. Bacterial antibiotic resistance studies using in vitro dynamic models: Population analysis vs. susceptibility testing as endpoints of mutant enrichment.
Firsov AA; Strukova EN; Portnoy YA; Shlykova DS; Zinner SH
Int J Antimicrob Agents; 2015 Sep; 46(3):313-8. PubMed ID: 26297633
[TBL] [Abstract][Full Text] [Related]
12. Selection of linezolid-resistant Enterococcus faecium in an in vitro dynamic model: protective effect of doxycycline.
Zinner SH; Gilbert D; Lubenko IY; Greer K; Firsov AA
J Antimicrob Chemother; 2008 Mar; 61(3):629-35. PubMed ID: 18245198
[TBL] [Abstract][Full Text] [Related]
13. Linezolid pharmacodynamics with Staphylococcus aureus in an in vitro dynamic model.
Strukova EN; Smirnova MV; Vostrov SN; Lubenko IY; Firsov AA; Zinner SH; Portnoy YA
Int J Antimicrob Agents; 2009 Mar; 33(3):251-4. PubMed ID: 19095420
[TBL] [Abstract][Full Text] [Related]
14. Predicting effects of antibiotic combinations using MICs determined at pharmacokinetically derived concentration ratios: in vitro model studies with linezolid- and rifampicin-exposed Staphylococcus aureus.
Golikova MV; Strukova EN; Portnoy YA; Dovzhenko SA; Kobrin MB; Zinner SH; Firsov AA
J Chemother; 2017 Oct; 29(5):267-273. PubMed ID: 28192070
[TBL] [Abstract][Full Text] [Related]
15. Searching for the Optimal Predictor of Ciprofloxacin Resistance in Klebsiella pneumoniae by Using In Vitro Dynamic Models.
Strukova EN; Portnoy YA; Romanov AV; Edelstein MV; Zinner SH; Firsov AA
Antimicrob Agents Chemother; 2015 Dec; 60(3):1208-15. PubMed ID: 26643328
[TBL] [Abstract][Full Text] [Related]
16. Concentration-resistance relationships with Pseudomonas aeruginosa exposed to doripenem and ciprofloxacin in an in vitro model.
Zinner SH; Gilbert D; Greer K; Portnoy YA; Firsov AA
J Antimicrob Chemother; 2013 Apr; 68(4):881-7. PubMed ID: 23175594
[TBL] [Abstract][Full Text] [Related]
17. Bacterial resistance studies using in vitro dynamic models: the predictive power of the mutant prevention and minimum inhibitory antibiotic concentrations.
Firsov AA; Strukova EN; Shlykova DS; Portnoy YA; Kozyreva VK; Edelstein MV; Dovzhenko SA; Kobrin MB; Zinner SH
Antimicrob Agents Chemother; 2013 Oct; 57(10):4956-62. PubMed ID: 23896481
[TBL] [Abstract][Full Text] [Related]
18. Emergence of resistant Streptococcus pneumoniae in an in vitro dynamic model that simulates moxifloxacin concentrations inside and outside the mutant selection window: related changes in susceptibility, resistance frequency and bacterial killing.
Zinner SH; Lubenko IY; Gilbert D; Simmons K; Zhao X; Drlica K; Firsov AA
J Antimicrob Chemother; 2003 Oct; 52(4):616-22. PubMed ID: 12951352
[TBL] [Abstract][Full Text] [Related]
19. Antistaphylococcal activity of DX-619, a new des-F(6)-quinolone, compared to those of other agents.
Bogdanovich T; Esel D; Kelly LM; Bozdogan B; Credito K; Lin G; Smith K; Ednie LM; Hoellman DB; Appelbaum PC
Antimicrob Agents Chemother; 2005 Aug; 49(8):3325-33. PubMed ID: 16048943
[TBL] [Abstract][Full Text] [Related]
20. Telavancin and vancomycin pharmacodynamics with Staphylococcus aureus in an in vitro dynamic model.
Lubenko IY; Strukova EV; Smirnova MV; Vostrov SN; Portnoy YA; Zinner SH; Firsov AA
J Antimicrob Chemother; 2008 Nov; 62(5):1065-9. PubMed ID: 18635520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
